132 related articles for article (PubMed ID: 14691448)
1. Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice.
Ko J; Shin SM; Oh YM; Lee YS; Ryoo ZY; Lee YH; Na DS; Kim JW
Oncogene; 2004 Mar; 23(10):1950-3. PubMed ID: 14691448
[TBL] [Abstract][Full Text] [Related]
2. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
[TBL] [Abstract][Full Text] [Related]
3. The HCCR oncoprotein as a biomarker for human breast cancer.
Jung SS; Park HS; Lee IJ; Namkoong H; Shin SM; Cho GW; Ha SA; Park YG; Lee YS; Ko J; Kim JW
Clin Cancer Res; 2005 Nov; 11(21):7700-8. PubMed ID: 16278390
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model.
Yoshidome K; Shibata MA; Maroulakou IG; Liu ML; Jorcyk CL; Gold LG; Welch VN; Green JE
Int J Oncol; 1998 Feb; 12(2):449-53. PubMed ID: 9458374
[TBL] [Abstract][Full Text] [Related]
5. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
Jonkers J; Meuwissen R; van der Gulden H; Peterse H; van der Valk M; Berns A
Nat Genet; 2001 Dec; 29(4):418-25. PubMed ID: 11694875
[TBL] [Abstract][Full Text] [Related]
6. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
[TBL] [Abstract][Full Text] [Related]
7. The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression.
Cho GW; Shin SM; Namkoong H; Kim HK; Ha SA; Hur SY; Kim TE; Chai YG; Kim JW
Gene; 2006 Dec; 384():18-26. PubMed ID: 16949218
[TBL] [Abstract][Full Text] [Related]
8. HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis.
Shin SM; Chung YJ; Oh ST; Jeon HM; Hwang LJ; Namkoong H; Kim HK; Cho GW; Hur SY; Kim TE; Lee YS; Park YG; Ko J; Kim JW
Gastroenterology; 2006 Jun; 130(7):2074-86. PubMed ID: 16762630
[TBL] [Abstract][Full Text] [Related]
9. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
10. HCCRBP-3 induces tumorigenesis through direct interaction with HCCR-1 in human cancers.
Ha SA; Kim HK; Yoo JA; Kim S; Shin SM; Gong GH; Lee YK; Kim JW
Mol Carcinog; 2014 Jan; 53(1):30-7. PubMed ID: 22851403
[TBL] [Abstract][Full Text] [Related]
11. HCCRBP-1 directly interacting with HCCR-1 induces tumorigenesis through P53 stabilization.
Ha SA; Shin SM; Lee YJ; Kim S; Kim HK; Namkoong H; Lee H; Lee YS; Cho YS; Park YG; Jeon HM; Oh C; Kim JW
Int J Cancer; 2008 Feb; 122(3):501-8. PubMed ID: 17943721
[TBL] [Abstract][Full Text] [Related]
12. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY
Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107
[TBL] [Abstract][Full Text] [Related]
14. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
15. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
Jacquemart IC; Springs AE; Chen WY
Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
[TBL] [Abstract][Full Text] [Related]
16. The role of X-linked genes in breast cancer.
Thakur A; Xu H; Wang Y; Bollig A; Biliran H; Liao JD
Breast Cancer Res Treat; 2005 Sep; 93(2):135-43. PubMed ID: 16187233
[TBL] [Abstract][Full Text] [Related]
17. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
Provinciali M; Papalini F; Orlando F; Pierpaoli S; Donnini A; Morazzoni P; Riva A; Smorlesi A
Cancer Res; 2007 Mar; 67(5):2022-9. PubMed ID: 17332330
[TBL] [Abstract][Full Text] [Related]
18. Dual action of apolipoprotein E-interacting HCCR-1 oncoprotein and its implication for breast cancer and obesity.
Ha SA; Shin SM; Kim HK; Kim S; Namkoong H; Lee YS; Kim HJ; Jung SM; Lee YS; Chung YJ; Park YG; Jung SS; Kim JW
J Cell Mol Med; 2009 Sep; 13(9B):3868-75. PubMed ID: 20196787
[TBL] [Abstract][Full Text] [Related]
19. PEG10 is a c-MYC target gene in cancer cells.
Li CM; Margolin AA; Salas M; Memeo L; Mansukhani M; Hibshoosh H; Szabolcs M; Klinakis A; Tycko B
Cancer Res; 2006 Jan; 66(2):665-72. PubMed ID: 16423995
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mouse models of human breast cancer.
Hutchinson JN; Muller WJ
Oncogene; 2000 Dec; 19(53):6130-7. PubMed ID: 11156526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
